Limitations of the human-PBL-SCID mouse model for vaginal transmission of HIV-1

American Journal of Reproductive Immunology

Volumn 57, Issue 5, 2007, Pages 353-360

  D'Cruz, Osmond J ^a,b   Uckun, Fatih M ^a,b  

^a PARKER HUGHES INSTITUTE   (United States)

^b Paradigm Pharmaceuticals   (United States)

Author keywords

HIV AIDS; Human SCID mice; Intravaginal; Microbicides; Sexual transmission

Indexed keywords

VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PERITONEUM LAVAGE; PRIORITY JOURNAL; SPERM; SPLEEN; VAGINA; VIRUS ISOLATION; VIRUS LOAD; VIRUS TRANSMISSION;

ANIMALS; ASCITIC FLUID; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES; MALE; MICE; MICE, SCID; POLYMERASE CHAIN REACTION; RNA, VIRAL; SPLEEN; TIME FACTORS; VAGINA; VIRAL LOAD;

EID: 34247120692     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00478.x     Document Type: Article

References (41)

1. Mosier DE, Gulizia RJ, Baird SM, Wilson DB, Spector DH, Spector SA: Human immunodeficiency virus infection of human-PBL-SCID mice. Science 1991; 251:791-794.
2. Di Fabio S, Giannini G, Lapenta C, Spada M, Binelli A, Germinario E, Sestili P, Belardelli F, Proietti E, Vella S: Vaginal transmission of HIV-1 in hu-SCID mice: A new model for the evaluation of vaginal microbicides. AIDS 2001; 15:2231-2238.
3. Khanna KV, Whaley KJ, Zeitlin L, Moench TR, Mehrazar K, Cone RA, Liao Z, Hildreth JE, Hoen TE, Shultz L, Markham RB: Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest 2002; 109:205-211.
4. D'CAuz OJ, Samuel P, Uckun FM: PHI-443: a novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide. Biol Reprod 2004; 71:2037-2047.
5. D'Cruz OJ, Uckun FM: Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide. Mol Hum Reprod 2005; 11:767-777.
6. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Transfer of functional immune system to mice with severe combined immunodeficiency. Nature 1988; 335:256-259.
7. Tary-Lehmann M, Saxon A, Lehmanna PV: The human immune system in hu-PBL-SCID mice. Immunol Today 1995; 16: 529-533.
8. Mosier DE, Picchio GR, Gulizia RJ, Sabbe R, Poignard P, Picard L, Offord RE, Thompson DA, Wilkin J: Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J Virol 1999; 73: 3544-3550.
9. Boyle MJ, Connors M, Flanigan ME, Geiger SP, Ford H, Jr, Baseler M, Adelsberger J, Davey RT, Jr, Lane HC: The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy. J Immunol 1995; 154:6612-6623.
10. McCune JM, Namikawa R, Shih CC, Rabin L, Kaneshima H: Suppression of HIV infection in AZT-treated SCID-hu mice. Science 1990; 247:564-566.
11. Uckun FM, Qazi S, Pendergrass S, Lisowski E, Waurzyniak B, Chen CL, Venkatachalam T: In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5′-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice. Antimicrob Agents Chemother 2002; 46:3428-3436.
12. Pettoello-Mantovani M, Kollmann TR, Raker C, Kim A, Yurasov S, Tudor R, Wiltshire H, Goldstein H: Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: An in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues. Antimicrob Agents Chemother 1997; 41:1880-1887.
13. Di Fabio S, Van Roey J, Giannini G, van den Mooter G, Spada M, Binelli A, Pirillo MF, Germinario E, Belardelli F, de Bethune MP, Vella S: Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation. AIDS 2003; 17:1597-1604.
14. Chancey CJ, Khanna KV, Seegers JFML, Zhang GW, Hildreth J, Langan A, Markham RB: Lactobacilli-expressed single-chain variable fragment (scFv) specific for intercellular adhesion molecule 1 (ICAM-1) blocks cell-associated HIV-1 transmission across a cervical epithelial monolayer. J Immunol 2006; 176:5627-5636.
15. Manson KH, Wyand MS, Miller C, Neurath AR: Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys. Antimicrob Agents Chemother 2000; 44:3199-3202.
16. Tsai CC, Emau P, Jiang Y, Agy MB, Shattock RJ, Schmidt A, Morton WR, Gustafson KR, Boyd MR: Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res Hum Retroviruses 2004; 20:11-18.
17. Bishop SA, Stokes CR, Gruffydd-Jones TJ, Whiting CV, Harbour DA: Vaginal and rectal infection of cats with feline immunodeficiency virus. Vet Microb 1996; 51:217-227.
18. Miller CJ, Alexander NJ, Vogel P, Anderson J, Marx PA: Mechanism of genital transmission of SIV: A hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J Med Primatol 1992; 21:64-68.
19. Veazey RS, Klasse PJ, Schader SM, Hu Q, Ketas TJ, Lu M, Marx PA, Dufour J, Colonno RJ, Shattock RJ, Springer MS, Moore JP: Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 2005; 438:99-102.
20. D'Cruz OJ, Waurzyniak B, Uckun FM: Antiretroviral spermicide WHI-07 prevents vaginal and rectal transmission of feline immunodeficiency virus in domestic cats. Antimicrob Agents Chemother 2004; 48:1082-1088.
21. Boadi T, Schneider E, Chung S, Tsai L, Gettie A, RAtterree M, Blanchard J, Neurath AR, Cheng-Mayer C: Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and CCR5 simian/human immunodeficiency virus. AIDS 2005; 19:1587-1594.
22. Kim CN, Adams DR, Bashirian S, Butera S, Folks TM, Otten RA: Repetitive exposures with simian/human immunodeficiency viruses: Strategy to study HIV pre-clinical interventions in non-human primates. J Med Primatol 2006; 35:210-216.
23. Ratterree M, Gettie A, Williams V, Malenbaum S, Neurath AR, Cheng-Mayer C, Blanchard J: Safety and distribution of cellulose acetate 1,2-benzenedicarboxylate (CAP), a candidate anti-HIV microbicide in rhesus macaques. AIDS 2005; 19:1595-1599.
24. D'Cruz OJ, Uckun FM: Clinical development of microbicides for the prevention of HIV infection. Curr Pharm Des 2004; 10:315-336.
25. Willett BJ, Flynn JN, Hosie MA: FIV infection of the domestic cat: an animal model for AIDS. Immunol Today 1997; 18:182-189.
26. North TW, North GL, Pedersen NC: Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immunodeficiency syndrome. Antimicrob Agents Chemother 1989; 34:1505-1507.
27. Bendinelli M, Pistello M, Lombardi S, Poli A, Garzelli C, Matteucci D, Ceccherini-Nelli L, Malvaldi G, Tozzini F: Feline immunodeficiency virus: An interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev 1995; 8:87-112.
28. Obert LA, Hoover EA: Feline immunodeficiency virus clade C mucosal transmission and disease courses. AIDS Res Hum Retroviruses 2000; 16:677-688.
29. Jordan HL, Howard J, Sellon RK, Wildt DE, Tompkins WA, Kennedy-Stoskopf S: Transmission of feline immunodeficiency virus in domestic cats via artificial insemination. J Virol 1996; 70:8224-8228.
30. Amacker M, Hubscher U: Chimeric HIV-1 and feline immunodeficiency virus reverse transcriptases: Critical role of the p51 subunit in the structural integrity of heterodimeric lentiviral DNA polymerases. J Mol Biol 1998; 278:757-765.
31. Auwerx JA, North TW, Preston BD, Klarmann GJ, De Clercq E, Balzarini J: Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: Role of the subunits in resistance/ sensitivity to non-nucleoside reverse transcriptase inhibitors. Mol Pharmacol 2002; 61:400-406.
32. Kaneshima H, Shih C-C, Namikawa R, Rabin L, Outzen H, Machado S, McCune JM: HIV infection of human lymph nodes in the SCID-Au mouse: a useful small animal model for testing the efficacy of antiviral compounds. Proc Natl Acad Sci U S A 1991; 88:4523-4527.
33. Uckun FM, Rajamohan F, Pendergrass S, Ozer Z, Waurzyniak B, Mao C: Structure-based design and engineering of a nontoxic recombinant pokeweed antiviral protein with potent anti-human immunodeficiency virus activity. Antimicrob Agents Chemother 2003; 47:1052-1061.
34. Zhu T, Wang N, Carr A, Nam DS, Moor-Jankowski R, Cooper DA, Ho DD: Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996; 70:3098-3107.
35. Kollmann TR, Pettoello-Mantovani M, Zhuang X, Kim A, Hachamovitch M, Smarnworawong P, Rubinstein A, Goldstein H: Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. J Exp Med 1994; 179:513-522.
36. Furuta T, Ito M, Kuramochi T, Hioki K, Nomura T: Effect of sulfamethoxazole-trimethoprim and sulfadoxine-primethamine against fatal pneumocystosis in SCID mice. J Protozool 1991; 38:221S-222S.
37. Markham RB, Schwartz DH, Templeton A, Margolick JB, Farzadegan H, Vlahov D, Yu XF: Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood mononuclear cells. J Virol 1996; 70:6947-6954.
38. Smith PD, Li L, Meng G: Mucosal events in the pathogenesis of human immunodeficiency virus type 1 infection. J Infect Dis 1999; 179(Suppl.3):S436-S440.
39. Krowka J, Sarin S, Namikawa R, McCune JM, Kaneshima H: The human T cells of the SCID-hu mouse are phenotypically normal and functionally competent. J Immunol 1991; 145:3751-3756.
40. Namikawa R, Kaneshima H, Lieberman M, Weissman IL, McCune JM: Infection of the SCID-hu mouse by HIV-1. Science 1988; 242:1684-1687.
41. Aldrovandi GM, Feuer G, Gao L, Jamieson B, Kristeva M, Chen IS, Zack JA: The SCID-hu mouse as a model for HIV-1 infection. Nature 1993; 363:732-736.